Pages that link to "Q35826756"
Jump to navigation
Jump to search
The following pages link to Tyrosine kinase inhibitors in cancer therapy (Q35826756):
Displaying 50 items.
- Optimization of substituted 6-salicyl-4-anilinoquinazoline derivatives as dual EGFR/HER2 tyrosine kinase inhibitors (Q28535038) (← links)
- Apoptosis-inducing effects of two anthraquinones from Hedyotis diffusa WILLD. (Q31157350) (← links)
- The marine-derived oligosaccharide sulfate (MdOS), a novel multiple tyrosine kinase inhibitor, combats tumor angiogenesis both in vitro and in vivo (Q33385649) (← links)
- Sequence and structure signatures of cancer mutation hotspots in protein kinases (Q33510934) (← links)
- Kinome-wide interaction modelling using alignment-based and alignment-independent approaches for kinase description and linear and non-linear data analysis techniques (Q33612912) (← links)
- Inhibition of protein kinases by anticancer DNA intercalator, 4-butylaminopyrimido[4',5':4,5]thieno(2,3-b)quinoline (Q33682972) (← links)
- Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer (Q33732190) (← links)
- Synthesis and biological activity of N(4)-phenylsubstituted-6-(2,4-dichloro phenylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic and antitumor agents (Q33847057) (← links)
- Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death (Q33939339) (← links)
- Diagnostic molecular pathology, part 2: proteomics and clinical applications of molecular diagnostics in hematopathology (Q33945053) (← links)
- Peptide reporters of kinase activity in whole cell lysates (Q34038376) (← links)
- Angiogenesis inhibitors: current strategies and future prospects (Q34056376) (← links)
- Properties of resistant cells generated from lung cancer cell lines treated with EGFR inhibitors (Q34203720) (← links)
- Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review (Q34433781) (← links)
- Tyrosine kinase inhibitors: Multi-targeted or single-targeted? (Q34983846) (← links)
- Limited dynamic range of immune response gene expression observed in healthy blood donors using RT-PCR. (Q35113710) (← links)
- N⁴-Aryl-6-substitutedphenylmethyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as receptor tyrosine kinase inhibitors (Q35747449) (← links)
- Characterization of the G-quadruplexes in the duplex nuclease hypersensitive element of the PDGF-A promoter and modulation of PDGF-A promoter activity by TMPyP4 (Q36360588) (← links)
- Targeting the RNA-binding protein Sam68 as a treatment for cancer? (Q36967302) (← links)
- Tyrosine kinase inhibitors in pediatric malignancies (Q36977823) (← links)
- 4-isothiocyanate-2, 2, 6, 6-tetramethyl piperidinooxyl inhibits angiogenesis by suppressing VEGFR2 and Tie2 phosphorylation (Q37288299) (← links)
- Imaging in early phase childhood cancer trials (Q37350870) (← links)
- Hydrogel-based protein array for quantifying epidermal growth factor receptor activity in cell lysates (Q37379240) (← links)
- Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors. (Q37385584) (← links)
- Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors (Q37613072) (← links)
- Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma (Q37702126) (← links)
- Oxidative stress-associated protein tyrosine kinases and phosphatases in Fanconi anemia (Q37716059) (← links)
- Receptor tyrosine kinase inhibitors: molecularly targeted drugs for veterinary cancer therapy (Q38033672) (← links)
- Kinase dysfunction and kinase inhibitors (Q38075152) (← links)
- Targeting tyrosine-kinases in ovarian cancer (Q38118388) (← links)
- Divide and conquer: subproteomic approaches toward gastric cancer biomarker and drug target discovery (Q38200653) (← links)
- An overview of early investigational therapies for chemoresistant ovarian cancer. (Q38553247) (← links)
- Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer Activity (Q38803278) (← links)
- Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studies (Q38854542) (← links)
- Antitumor evaluation and molecular docking study of substituted 2-benzylidenebutane-1,3-dione, 2-hydrazonobutane-1,3-dione and trifluoromethyl-1H-pyrazole analogues. (Q38932398) (← links)
- N-Phenyl-2-p-tolylthiazole-4-carboxamide derivatives: Synthesis and cytotoxicity evaluation as anticancer agents (Q38937389) (← links)
- Structure-functional prediction and analysis of cancer mutation effects in protein kinases. (Q38987589) (← links)
- Design and synthesis of quinazolinone tagged acridones as cytotoxic agents and their effects on EGFR tyrosine kinase (Q38991074) (← links)
- Discovery of 2-phenyl-N-(5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)acetamide derivatives as apoptosis inducers via the caspase pathway with potential anticancer activity (Q39079425) (← links)
- Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment. (Q39109514) (← links)
- Macroporous hydrogel micropillars for quantifying Met kinase activity in cancer cell lysates (Q39311676) (← links)
- Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: Search for anticancer agent (Q39565841) (← links)
- Antitumor activity of a novel EGFR tyrosine kinase inhibitor against human lung carcinoma in vitro and in vivo (Q39980200) (← links)
- Derivatives of Iressa, a specific epidermal growth factor receptor inhibitor, are powerful apoptosis inducers in PC3 prostatic cancer cells (Q40186131) (← links)
- Tannic acid, a potent inhibitor of epidermal growth factor receptor tyrosine kinase (Q40299378) (← links)
- Synergistic enhancement of the potency and selectivity of small molecule transcriptional inhibitors (Q41470556) (← links)
- Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis (Q42045872) (← links)
- Models for the prediction of receptor tyrosine kinase inhibitory activity of substituted 3-aminoindazole analogues. (Q42205929) (← links)
- An Alignment-Independent 3D-QSAR Study of FGFR2 Tyrosine Kinase Inhibitors (Q42658205) (← links)
- Tyrosine phosphorylation modulates the vascular responses of mesenteric arteries from human colorectal tumors. (Q42864506) (← links)